Status
Terminated
Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this unapproved drug.
Status
Terminated
Classification
Class I
Report Date
May 1, 2024
Termination Date
June 13, 2024